Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Operating Margin: 2009-2019

Historic Operating Margin for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to 9.17%.

  • Neurocrine Biosciences' Operating Margin rose 3217.00% to 15.03% in Q3 2021 from the same period last year, while for Sep 2021 it was 8.84%, marking a year-over-year decrease of 460.00%. This contributed to the annual value of 9.17% for FY2019, which is 99.00% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Operating Margin of 9.17% as of FY2019, which was up 12.16% from 8.18% recorded in FY2018.
  • Neurocrine Biosciences' 5-year Operating Margin high stood at 9.17% for FY2019, and its period low was -982.48% during FY2016.
  • For the 3-year period, Neurocrine Biosciences' Operating Margin averaged around -286.13%, with its median value being 8.18% (2018).
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by 50,671bps in 2016, then spiked by 88,392bps in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Operating Margin (Yearly) stood at -475.77% in 2015, then tumbled by 50,671bps to -982.48% in 2016, then soared by 10,674bps to -875.74% in 2017, then skyrocketed by 88,392bps to 8.18% in 2018, then skyrocketed by 99bps to 9.17% in 2019.